Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy

BACKGROUND: Few studies have clearly identified the prognostic factors in patients with advanced biliary tract cancer (BTC) receiving gemcitabine plus cisplatin (GC) which is acknowledged as standard chemotherapy regimen. OBJECTIVES: The aim of this study was to identify predictive factors of the ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Yuko, Kan, Motoyasu, Kimura, Gen, Umemoto, Kumiko, Watanabe, Kazuo, Sasaki, Mitsuhito, Takahashi, Hideaki, Hashimoto, Yusuke, Imaoka, Hiroshi, Ohno, Izumi, Mitsunaga, Shuichi, Ikeda, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Original Article—Liver, Pancreas, and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394712/
https://www.ncbi.nlm.nih.gov/pubmed/30298469
http://dx.doi.org/10.1007/s00535-018-1518-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394712/
https://www.ncbi.nlm.nih.gov/pubmed/30298469
http://dx.doi.org/10.1007/s00535-018-1518-3

Ejemplares similares